EASL Studio Policy Dialogues Episode 3 - Liver Cancer: The Risk of Ignorance

EASL Studio - Season 1, Episode 3 - The EASL-Lancet Liver CommissionПодробнее

EASL Policy Dialogues S2E7 - Inequality in liver care – Identifying and addressing disparitiesПодробнее

EASL Studio Policy Dialogues - Episode 1 - Drug use, viral hepatitis, and EuropeПодробнее

EASL Studio Policy Dialogues - Episode 2 - The liver, alcohol, and politicsПодробнее

Disclaimer III & IV (Recap and Analysis)Подробнее

EASL Policy Dialogues S3E1 - Rarity and parity – Addressing inequities in rare liver diseaseПодробнее

EASL Studio Policy Dialogues Ep5 - The lives of liver patients: Prejudice and stigmaПодробнее

EASL Studio - S5E13 Promo - Basics in decision-making for liver cancer treatmentПодробнее

EASL Studio Policy Dialogues Ep4 - Fatty Liver Disease: The Approaching Tsunami in NCDsПодробнее

EASL Studio - Season 1, Episode 1 - Liver Cancer Awareness MonthПодробнее

EASL Policy Dialogues S2E9 - Preventing liver disease with policy measures: The Hepahealth II studyПодробнее

EASL Studio S05E13 - Basics in decision-making for liver cancer treatmentПодробнее

EASL Policy Dialogue Episode 2 - World Liver Day - 19 April 2023Подробнее

EASL Policy Dialogues - EASL’s statement: Key asks to the EU for the LiverПодробнее

EASL Studio - S3E2 - Liver transplantation for ACLF: Opportunities, challenges and pitfallsПодробнее

EASL Studio -S3E12- Meeting the challenge of AMR in cirrhosis: the invisible threat that lies withinПодробнее

EASL Studio S6E7- The impact of policy measure in preventing liver diseases: The Hepahealth II studyПодробнее

EASL Studio - S3E16 - Liver cancer in 2022: Wrap-up & outlookПодробнее